AAAAAA
Results:
1-18
|
Results: 18
Authors:
Kirn, D
Martuza, RL
Zwiebel, J
Citation: D. Kirn et al., Replication-selective virotherapy for cancer: Biological principles, risk management and future directions, NAT MED, 7(7), 2001, pp. 783-789
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
VonHoff, DD
Kaye, SB
Citation: I. Ganly et al., A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 7(3), 2001, pp. 754-754
Authors:
Mulvihlll, S
Warren, R
Venook, A
Adler, A
Randlev, B
Heise, C
Kirn, D
Citation: S. Mulvihlll et al., Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial, GENE THER, 8(4), 2001, pp. 308-315
Authors:
Reid, T
Galanis, E
Abbruzzese, J
Sze, D
Andrews, J
Romel, L
Hatfield, M
Rubin, J
Kirn, D
Citation: T. Reid et al., Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase Itrial, GENE THER, 8(21), 2001, pp. 1618-1626
Authors:
Kirn, D
Citation: D. Kirn, Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?, GENE THER, 8(2), 2001, pp. 89-98
Authors:
Nemunaitis, J
Cunningham, C
Buchanan, A
Blackburn, A
Edelman, G
Maples, P
Netto, G
Tong, A
Randlev, B
Olson, S
Kirn, D
Citation: J. Nemunaitis et al., Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity, GENE THER, 8(10), 2001, pp. 746-759
Authors:
Nemunaitis, J
Khuri, F
Ganly, I
Arseneau, J
Posner, M
Vokes, E
Kuhn, J
McCarty, T
Landers, S
Blackburn, A
Romel, L
Randlev, B
Kaye, S
Kirn, D
Citation: J. Nemunaitis et al., Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer, J CL ONCOL, 19(2), 2001, pp. 289-298
Authors:
Heise, C
Hermiston, T
Johnson, L
Brooks, G
Sampson-Johannes, A
Williams, A
Hawkins, L
Kirn, D
Citation: C. Heise et al., An adenovirus E1A mutant that demonstrates potent and selective systemic antitumoral efficacy (vol 6, pg 1134, 2000), NAT MED, 6(12), 2000, pp. 1412-1412
Authors:
Heise, C
Hermiston, T
Johnson, L
Brooks, G
Sampson-Johannes, A
Williams, A
Hawkins, L
Kirn, D
Citation: C. Heise et al., An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy, NAT MED, 6(10), 2000, pp. 1134-1139
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
VonHoff, DD
Kaye, SB
Citation: I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intramorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 6(9), 2000, pp. 3797-3797
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
Von Hoff, DD
Kaye, SB
Citation: I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer, CLIN CANC R, 6(3), 2000, pp. 798-806
Authors:
Heise, C
Lemmon, M
Kirn, D
Citation: C. Heise et al., Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: Dependence on sequencing but not p53 functional status or route of administration, CLIN CANC R, 6(12), 2000, pp. 4908-4914
Authors:
Heise, C
Ganly, I
Kim, YT
Sampson-Johannes, A
Brown, R
Kirn, D
Citation: C. Heise et al., Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status, GENE THER, 7(22), 2000, pp. 1925-1929
Authors:
Kirn, D
Citation: D. Kirn, Replication-selective oncolytic adenoviruses: virotherapy aimed at genetictargets in cancer, ONCOGENE, 19(56), 2000, pp. 6660-6669
Authors:
Ahram, M
Sameni, M
Qiu, RG
Linebaugh, B
Kirn, D
Sloane, BF
Citation: M. Ahram et al., Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix, EXP CELL RE, 260(2), 2000, pp. 292-303
Authors:
Nemunaitis, J
Ganly, I
Khuri, F
Arseneau, J
Kuhn, J
McCarty, T
Landers, S
Maples, P
Romel, L
Randlev, B
Reid, T
Kaye, S
Kirn, D
Citation: J. Nemunaitis et al., Selective replication and oncolysis in p53 mutant tumors with ONYX-015, anE1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A Phase II trial, CANCER RES, 60(22), 2000, pp. 6359-6366
Authors:
Kirn, D
Hermiston, T
Citation: D. Kirn et T. Hermiston, Induction of an oncogenic fusion protein by a viral gene - a new chapter in an old story, NAT MED, 5(9), 1999, pp. 991-992
Authors:
Kirn, D
Hermiston, T
McCormick, F
Citation: D. Kirn et al., ONYX-015: Clinical data are encouraging, NAT MED, 4(12), 1998, pp. 1341-1342
Risultati:
1-18
|